Aktie A2P79J INSPYR THERAPEUTICS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Inspyr Therapeutics, Inc. Other OTC

Aktien

A2P79J

US45782A4031

NSPX

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Rebus Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Rebus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Rebus Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Rebus Holdings, Inc. Auditor Raises 'Going Concern' Doubt
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN
Rebus Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)
REBUS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)
Rebus : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)
Rebus Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN
Rebus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Rebus Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
REBUS HOLDINGS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Rebus Holdings, Inc. Auditor Raises 'Going Concern' Doubt
NOTE 2 - MANAGEMENT'S PLANS TO CONTINUE AS A GOING CONCERN
Rebus Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Inspyr Therapeutics : Material Event - Form 8-K/A
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3C9XX Aktie
  4. A2P79J Aktie
  5. Nachrichten Inspyr Therapeutics, Inc.
  6. Andere Sprachen